These benefits, together with a former report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the thought of focusing on ACKR3 as a novel solution to modulate the opioid system, which could open new therapeutic avenues for opioid-related Problems. Conolidine promises for being a https://erici515qyy6.spintheblog.com/profile